Trial Profile
Phase I, single-blind, randomized, placebo-controlled, parallel, single and multiple ascending dose study to evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of bilastine in healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2016
Price :
$35
*
At a glance
- Drugs Bilastine (Primary)
- Indications Allergic rhinitis; Urticaria
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Taiho Pharmaceutical
- 08 Oct 2016 New trial record